InvestorsHub Logo
Followers 35
Posts 4671
Boards Moderated 0
Alias Born 12/14/2013

Re: Biobillionair post# 217973

Monday, 10/07/2019 7:29:40 AM

Monday, October 07, 2019 7:29:40 AM

Post# of 424782
BB, I wish I could agree with others

that FDA has done and is doing a great job with Amarin & Vascepa

But FDA actions

as initially verified by Amarin's past lawsuits with FDA

proves otherwise

Woodcock has been there through all of this

The negating of the expedited review and late notice of ADCOM

also suggests that FDA is not handling Amarin & Vascepa kindly

And then we have the FOIA requests by the law firm

And then the generic company actions

so (I believe) Amarin Management agrees with you

that FDA is not properly handling the Vascepa review & approval
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News